ICH adopts M14 guideline on observational studies

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Adverse eventsBiologics/ biosimilars/ vaccinesBiotechnologyGlobalICHPharmaceuticalsPharmacovigilanceQuality Assurance and ControlRegulatory Intelligence/PolicyRWE/RWD